Mouse Anti-APCS Recombinant Antibody (4E8) (CBMAB-A3046-YC)

Doni, A., Parente, R., Laface, I., Magrini, E., Cunha, C., Colombo, F. S., ... & Mantovani, A. (2021). Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus. Nature Communications, 12(1), 1-15.

Karhadkar, T. R., Pilling, D., & Gomer, R. H. (2021). Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice. Plos one, 16(1), e0245924.

Ma, J., Liu, Q., & White, J. R. (2021). Novel methods to determine complement activation in human serum induced by the complex of Dezamizumab and serum amyloid P. Journal of Biological Chemistry, 101136.

Larsen, C. P., Sharma, S. G., Caza, T. N., Kenan, D. J., Storey, A. J., Edmondson, R. D., ... & Arthur, J. M. (2020). Serum amyloid P deposition is a sensitive and specific feature of membranous-like glomerulopathy with masked IgG kappa deposits. Kidney international, 97(3), 602-608.

Scarale, M. G., Copetti, M., Garofolo, M., Fontana, A., Salvemini, L., De Cosmo, S., ... & Menzaghi, C. (2020). The synergic association of hs-CRP and serum amyloid P component in predicting all-cause mortality in patients with type 2 diabetes. Diabetes care, 43(5), 1025-1032.

Pilling, D., Cox, N., Thomson, M. A., Karhadkar, T. R., & Gomer, R. H. (2019). Serum Amyloid P and a Dendritic Cell–Specific Intercellular Adhesion Molecule-3–Grabbing Nonintegrin Ligand Inhibit High-Fat Diet–Induced Adipose Tissue and Liver Inflammation and Steatosis in Mice. The American journal of pathology, 189(12), 2400-2413.

Borthwick, N. J., Lane, T., Moyo, N., Crook, A., Shim, J. M., Baines, I., ... & Pepys, M. B. (2018). Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1. PloS one, 13(5), e0197299.

Pilling, D., & Gomer, R. H. (2018). The development of serum amyloid P as a possible therapeutic. Frontiers in immunology, 9, 2328.

Nagatoshi, A., Ueda, M., Ueda, A., Tasaki, M., Inoue, Y., Ma, Y., ... & Ando, Y. (2017). Serum amyloid P component: a novel potential player in vessel degeneration in CADASIL. Journal of the neurological sciences, 379, 69-76.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols